Physician profile
Nirmal Kaur
NPI 1114157302
$28,140.07
in general payments reported to CMS, 2019-2025
25 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $51.60 · 2021: $318 · 2022: $656 · 2023: $13K · 2024: $13K · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $1,427 · Travel and Lodging: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Food and Beverage | $1,427.06 |
| Travel and Lodging | $107.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,519.67 | 2020-2025 | 2cm Peripheral Cutting Balloon, Avvigo Guidance System |
| Abiomed | $574.11 | 2022-2025 | Impella |
| Medtronic Vascular, INC. | $249.72 | 2019 | |
| Penumbra, INC. | $232.21 | 2021-2025 | Indigo System |
| Asahi Intecc USA, INC. | $195.84 | 2023-2024 | Asahi Ptca Guide Wire, Peripheral Vascular |
| Cardiovascular Systems INC. | $181.48 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $163.18 | 2019-2022 | |
| Medtronic, INC. | $159.02 | 2024 | Onyx Frontier |
| Astrazeneca Pharmaceuticals Lp | $128.70 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.85 | 2021-2023 | Lifevest |
| Pfizer INC. | $117.98 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $98.69 | 2019 | |
| Amgen INC. | $76.09 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.58 | 2024-2025 | Jardiance |
| Inari Medical, INC. | $43.49 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $29.86 | 2019-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $29.39 | 2021-2025 | |
| Terumo Medical Corporation | $29.35 | 2024 | Metacross Otw |
| Edwards Lifesciences Corporation | $26.28 | 2021 | |
| Lantheus Medical Imaging, INC. | $23.06 | 2019 | |
| Dexcom, INC. | $22.24 | 2025 | Dexcom G6 Transmitter |
| Imperative Care, INC | $21.11 | 2025 | Symphony Catheter |
| Alnylam Pharmaceuticals INC. | $18.80 | 2025 | Onpattro |
| Cardinal Health 200 LLC | $15.81 | 2021 | |
| Philips North America LLC | $15.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirmal Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.